CASPIAN Trial: Clinical Implications of a 3-Year OS Update of Durvalumab +/- Tremelimumab + Platinum-Etoposide in 1L Treatment of ES-SCLC | VuMedi

Find latest Small Cell Lung Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

CASPIAN Trial: Clinical Implications of a 3-Year OS Update of Durvalumab +/- Tremelimumab + Platinum-Etoposide in 1L Treatment of ES-SCLC

By Niels Reinmuth 3 Videos

395 views

January 29, 2024

Comments 0

Login to view comments. Click here to Login